Serial Number
97915548
Owner
Genomic Health, Inc.Attorney
Sana HakimFirst Use Date
Mar 28, 2025
Filing Date
May 1, 2023
ONCODETECT Trademark
Serial Number: 97915548 • Registration: 7969494
Trademark Classes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Sana Hakim K&L GATES LLP
P.O. BOX 1135
CHICAGO, IL 60690-1135
United States
Trademark Details
Filing Date
May 1, 2023
Registration Date
September 30, 2025
First Use Anywhere
March 28, 2025
First Use in Commerce
March 28, 2025
Published for Opposition
July 9, 2024
Goods & Services
Providing laboratory research services in the field of genetic testing for the detection and screening of cancer, namely, development of assays for detection of tumor-specific biomarkers in tumor tissue and blood; medical and scientific laboratory services in the field of genetic testing for the detection and screening of cancer, namely, development of assays for detection of tumor-specific biomarkers in tumor tissue and blood
Blood collection kit comprised of blood collecting tubes for use in the detection of tumor-specific biomarkers in tumor tissue and blood testing for the recurrence of cancer and the ongoing monitoring of therapeutic effectiveness
Medical testing services, namely, genetic testing for the detection and screening of cancer, namely, use of a bespoke assay for detection of tumor-specific biomarkers in tumor tissue and blood, testing for the recurrence of cancer and the ongoing monitoring of therapeutic effectiveness; providing medical testing services for the detection and screening of cancer and information for treatment purposes in the field of genetic research and disease classification, namely, use of a bespoke assay for detection of tumor-specific biomarkers in tumor tissue and blood, testing for the recurrence of cancer and the ongoing monitoring of therapeutic effectiveness
